Member access

4-Traders Homepage  >  Shares  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX   US45822R1014

 SummaryNewsCalendarCompanyFinancials 
Company
IntelGenx Technologies Corp. operates as a drug delivery company. It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies. The company is a provider of product development services for the pharmaceutical industry,... 
More about the company
Financials ($)
Sales 2011 6,00 M
EBIT 2011 -0,10 M
Net income 2011 -0,10 M
Debt 2011 -
Yield 2011 -
Sales 2012 0,97 M
EBIT 2012 -1,88 M
Net income 2012 -2,14 M
Debt 2012 -
Yield 2012 -
PER 2011 46,29
PER 2012
Capi. / Sales 2011 7,92x
Capi. / Sales 2012 49,2x
Capitalization 47,5 M
More Financials
Latest news on INTELGENX TECHNOLOGIES COR
7d ago INTELGENX TECHNOLOGIES : 2014-04-16 IntelGenx Announces Receipt of an Additional..
7d ago IntelGenx Announces Receipt of an Additional U.S. Patent Allowance Related To..
03/18 INTELGENX TECHNOLOGIES : 2014-02-24 IntelGenx Achieves Positive Bioequivalence R..
03/18 INTELGENX TECHNOLOGIES : 2014-03-11 IntelGenx Reports 2013 Annual Results and Pr..
03/18 INTELGENX TECHNOLOGIES : 2014-03-03 IntelGenx and RedHill Biopharma Submit Respo..
03/18 INTELGENX TECHNOLOGIES : 2014-02-26 IntelGenx Announces Receipt of Two Additiona..
03/11 IntelGenx Reports 2013 Annual Results and Provides Corporate Development Upda..
03/03 IntelGenx and RedHill Biopharma Submit Response to FDA CRL for VersaFilm(TM) ..
02/26 IntelGenx Announces Receipt of Two Additional U.S. Patent Allowances Related ..
02/24 IntelGenx Achieves Positive Bioequivalence Results for Erectile Dysfunction V..
01/13 IntelGenx Announces Additional Development and Commercialization Agreement wi..
01/09 IntelGenx Grants Stock Options
More news
Comments 
Advertisement
Income Statement Evolution
IntelGenx Technologies Cor : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF